196 related articles for article (PubMed ID: 12715916)
21. Levels of immunoglobulin E specific to the major food allergen and chemokine (C-C motif) ligand (CCL)17/thymus and activation regulated chemokine and CCL22/macrophage-derived chemokine in infantile atopic dermatitis on Ishigaki Island.
Esaki H; Takeuchi S; Furusyo N; Yamamura K; Hayashida S; Tsuji G; Takemura M; Hayashi J; Furue M
J Dermatol; 2016 Nov; 43(11):1278-1282. PubMed ID: 27028543
[TBL] [Abstract][Full Text] [Related]
22. Regulation of macrophage-derived chemokine (MDC, CCL22) production.
Yamashita U; Kuroda E
Crit Rev Immunol; 2002; 22(2):105-14. PubMed ID: 12433129
[TBL] [Abstract][Full Text] [Related]
23. Suppressive effects of Bifidobacterium longum on the production of Th2-attracting chemokines induced with T cell-antigen-presenting cell interactions.
Iwabuchi N; Takahashi N; Xiao JZ; Yonezawa S; Yaeshima T; Iwatsuki K; Hachimura S
FEMS Immunol Med Microbiol; 2009 Apr; 55(3):324-34. PubMed ID: 19291170
[TBL] [Abstract][Full Text] [Related]
24. Serum levels of Th2 chemokines, CCL17, CCL22, and CCL27, were the important markers of severity in infantile atopic dermatitis.
Nakazato J; Kishida M; Kuroiwa R; Fujiwara J; Shimoda M; Shinomiya N
Pediatr Allergy Immunol; 2008 Nov; 19(7):605-13. PubMed ID: 18266834
[TBL] [Abstract][Full Text] [Related]
25. Presence of high contents of thymus and activation-regulated chemokine in platelets and elevated plasma levels of thymus and activation-regulated chemokine and macrophage-derived chemokine in patients with atopic dermatitis.
Fujisawa T; Fujisawa R; Kato Y; Nakayama T; Morita A; Katsumata H; Nishimori H; Iguchi K; Kamiya H; Gray PW; Chantry D; Suzuki R; Yoshie O
J Allergy Clin Immunol; 2002 Jul; 110(1):139-46. PubMed ID: 12110833
[TBL] [Abstract][Full Text] [Related]
26. Serum concentrations of CCR4 ligands in relation to clinical severity of atopic dermatitis in Egyptian children.
Mostafa GA; Tomoum HY; Salem SA; Abd El-Aziz MM; Abou El-Maged DI; El-Sayed El-Far I
Pediatr Allergy Immunol; 2008 Dec; 19(8):756-62. PubMed ID: 18435706
[TBL] [Abstract][Full Text] [Related]
27. Serum levels of the Th1 promoter IL-12 and the Th2 chemokine TARC are elevated in erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis and correlate with soluble Fas ligand expression. An immunoenzymatic study from the Italian Group of Immunopathology.
Quaglino P; Caproni M; Antiga E; Del Bianco E; Osella-Abate S; Savoia P; Frezzolini A; Schena D; Marzano A; Volpi W; De Simone C; Parodi A; Fabbri P; Bernengo MG;
Dermatology; 2007; 214(4):296-304. PubMed ID: 17460400
[TBL] [Abstract][Full Text] [Related]
28. TARC augments TNF-alpha-induced CTACK production in keratinocytes.
Vestergaard C; Johansen C; Christensen U; Just H; Hohwy T; Deleuran M
Exp Dermatol; 2004 Sep; 13(9):551-7. PubMed ID: 15335355
[TBL] [Abstract][Full Text] [Related]
29. Increased macrophage-derived chemokine in exhaled breath condensate and plasma from children with asthma.
Leung TF; Wong GW; Ko FW; Lam CW; Fok TF
Clin Exp Allergy; 2004 May; 34(5):786-91. PubMed ID: 15144472
[TBL] [Abstract][Full Text] [Related]
30. The development of atopic dermatitis is independent of Immunoglobulin E up-regulation in the K14-IL-4 SKH1 transgenic mouse model.
Chen L; Overbergh L; Mathieu C; Chan LS
Clin Exp Allergy; 2008 Aug; 38(8):1367-80. PubMed ID: 18489026
[TBL] [Abstract][Full Text] [Related]
31. Chemokines indicate allergic bronchopulmonary aspergillosis in patients with cystic fibrosis.
Hartl D; Latzin P; Zissel G; Krane M; Krauss-Etschmann S; Griese M
Am J Respir Crit Care Med; 2006 Jun; 173(12):1370-6. PubMed ID: 16543550
[TBL] [Abstract][Full Text] [Related]
32. Monocyte-derived dendritic cells exposed to Der p 1 allergen enhance the recruitment of Th2 cells: major involvement of the chemokines TARC/CCL17 and MDC/CCL22.
Hammad H; Smits HH; Ratajczak C; Nithiananthan A; Wierenga EA; Stewart GA; Jacquet A; Tonnel AB; Pestel J
Eur Cytokine Netw; 2003; 14(4):219-28. PubMed ID: 14715413
[TBL] [Abstract][Full Text] [Related]
33. Serum levels of cutaneous T-cell attracting chemokine (CTACK) as a laboratory marker of the severity of atopic dermatitis in children.
Hon KL; Leung TF; Ma KC; Li AM; Wong Y; Fok TF
Clin Exp Dermatol; 2004 May; 29(3):293-6. PubMed ID: 15115514
[TBL] [Abstract][Full Text] [Related]
34. Novel CC chemokine receptor 4 antagonist RS-1154 inhibits ovalbumin-induced ear swelling in mice.
Nakagami Y; Kawashima K; Yonekubo K; Etori M; Jojima T; Miyazaki S; Sawamura R; Hirahara K; Nara F; Yamashita M
Eur J Pharmacol; 2009 Dec; 624(1-3):38-44. PubMed ID: 19818758
[TBL] [Abstract][Full Text] [Related]
35. Production of TARC and MDC by naive T cells in asthmatic patients.
Hirata H; Arima M; Cheng G; Honda K; Fukushima F; Yoshida N; Eda F; Fukuda T
J Clin Immunol; 2003 Jan; 23(1):34-45. PubMed ID: 12645858
[TBL] [Abstract][Full Text] [Related]
36. Up-regulation of CCL17, CCL22 and CCR4 in drug-induced maculopapular exanthema.
Tapia B; Morel E; Martín-Díaz MA; Díaz R; Alves-Ferreira J; Rubio P; Padial A; Bellón T
Clin Exp Allergy; 2007 May; 37(5):704-13. PubMed ID: 17456218
[TBL] [Abstract][Full Text] [Related]
37. Macrophage-derived chemokine production by activated human T cells in vitro and in vivo: preferential association with the production of type 2 cytokines.
Galli G; Chantry D; Annunziato F; Romagnani P; Cosmi L; Lazzeri E; Manetti R; Maggi E; Gray PW; Romagnani S
Eur J Immunol; 2000 Jan; 30(1):204-10. PubMed ID: 10602042
[TBL] [Abstract][Full Text] [Related]
38. Inhibitory effect of 5,6-dihydroergosteol-glucoside on atopic dermatitis-like skin lesions via suppression of NF-κB and STAT activation.
Jung M; Lee TH; Oh HJ; Kim H; Son Y; Lee EH; Kim J
J Dermatol Sci; 2015 Sep; 79(3):252-61. PubMed ID: 26100037
[TBL] [Abstract][Full Text] [Related]
39. Chemokine receptor gene expression in giant papillae of atopic keratoconjunctivitis.
Yamagami S; Ebihara N; Amano SY
Mol Vis; 2005 Mar; 11():192-200. PubMed ID: 15788997
[TBL] [Abstract][Full Text] [Related]
40. Serum levels of a Th1 chemoattractant IP-10 and Th2 chemoattractants, TARC and MDC, are elevated in patients with systemic sclerosis.
Fujii H; Shimada Y; Hasegawa M; Takehara K; Sato S
J Dermatol Sci; 2004 Jun; 35(1):43-51. PubMed ID: 15194146
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
